1. Targeting the TWEAK–Fn14 pathway prevents dysfunction in cardiac calcium handling after acute kidney injury
    Jonay Poveda et al, 2023, The Journal of Pathology CrossRef
  2. Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway
    Shuang Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  3. Kinase inhibitors with viral oncolysis: Unmasking pharmacoviral approaches for cancer therapy
    Victoria Heather Gilchrist et al, 2020, Cytokine & Growth Factor Reviews CrossRef
  4. TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions
    Sarita Das et al, 2017, Cellular Oncology CrossRef
  5. Kinase inhibitors as potential agents in the treatment of multiple myeloma
    Hanley N. Abramson, 2016, Oncotarget CrossRef
  6. Oncolytic virotherapy – Forging its place in the immunomodulatory paradigm for Multiple Myeloma
    Joselle Cook et al, 2021, Cancer Treatment and Research Communications CrossRef
  7. Immunotherapy approaches for hematological cancers
    Olivia L. Lanier et al, 2022, iScience CrossRef
  8. Oncolytic virotherapy for urological cancers
    Zahid Delwar et al, 2016, Nature Reviews Urology CrossRef
  9. Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer
    XIUJUN HAN et al, 2015, Molecular Medicine Reports CrossRef
  10. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
    Zhi Zhu et al, 2022, Molecular Cancer CrossRef
  11. Influence and mechanism of 5-aminolevulinic acid-photodynamic therapy on the metastasis of esophageal carcinoma
    Xiaona Zhang et al, 2017, Photodiagnosis and Photodynamic Therapy CrossRef
  12. Oncolytic Immunotherapy for Treatment of Cancer
    A. Tsun et al, 2016, Progress in Cancer Immunotherapy CrossRef
  13. Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma
    Zhong-Zhe Lin et al, 2023, Cancer Letters CrossRef
  14. Oncolytic viruses: overcoming translational challenges
    Jordi Martinez-Quintanilla et al, 2019, Journal of Clinical Investigation CrossRef
  15. Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies
    Yongming Xi et al, 2015, Journal of Cellular Biochemistry CrossRef
  16. The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
    Jinqiong Jiang et al, 2021, Bioengineered CrossRef
  17. Paeoniflorin diminishes ConA-induced IL-8 production in primary human hepatic sinusoidal endothelial cells in the involvement of ERK1/2 and Akt phosphorylation
    Wen-Guang Gong et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef
  18. Targeted Management Strategies in Multiple Myeloma
    Shaji K. Kumar, 2019, The Cancer Journal CrossRef

  19. Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma


    Ying-Qi Feng et al, 2020, Drug Design, Development and Therapy CrossRef
  20. Targeting lung cancer stem‐like cells with TRAIL gene armed oncolytic adenovirus
    Yu Yang et al, 2015, Journal of Cellular and Molecular Medicine CrossRef
  21. An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancer
    Shanying Huang et al, 2023, Archives of Virology CrossRef
  22. Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis
    Darshak K. Bhatt et al, 2021, Vaccines CrossRef
  23. Phosphatidylinositol 3-kinase signaling inhibitors for treatment of multiple myeloma: From small molecules to microRNAs
    Mahshid Mehdizadeh et al, 2022, Journal of Oncology Pharmacy Practice CrossRef
  24. Oncolytic viruses in hematological malignancies: hijacking disease biology and fostering new promises for immune and cell-based therapies
    Mário Sousa-Pimenta et al, 2023, Viral Vectors in Cancer Immunotherapy CrossRef
  25. Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myeloma
    Ying Shen et al, 2018, Life Sciences CrossRef